Friedman S, Sillcocks D, Cantor H
Department of Pathology, Harvard Medical School, Boston, MA.
Immunogenetics. 1987;26(4-5):193-203. doi: 10.1007/BF00346512.
A T-cell clone (Ly1-03) derived from BALB/cBy mice, though highly specific for OVA/Ad, reacted to allogeneic spleen cells of 6 of 12 H-2 haplotypes tested. The reactivity to each particular H-2 haplotype required the expression of a non-major histocompatibility complex (MHC) gene product present on the B cells of certain strains of mice. All the alloreactive responses were MHC restricted and were inhibited by class II-specific and L3T4-specific monoclonal antibodies. The non-MHC gene product, X, is a new lymphocyte-stimulating determinant that is not expressed in mice with the xid defect. We favor a model that proposes two independent sites (or receptors) for X and the class II molecule. Contrary to previous models for alloreactivity, the anti-MHC site is not directed to a polymorphic receptor for self-class II epitope on the foreign class II molecule, but rather to a conserved determinant present on both self- and allo-class II molecules. If there is only one antigen receptor on the T-cell clone Ly1-03, then anti-X receptor must bind to a cross-reactive determinant found on immunogenic OVA and the non-MHC coded gene product expressed on the cell surface membrane. We further postulate that class II plus "X" recognition may be a general rule for alloreactive as well as autoreactive responses. Thus, both allo-class II and allo-class I reactive T cells are similar in that both bind a non-MHC coded gene product prior to activation.
从BALB/cBy小鼠获得的一个T细胞克隆(Ly1-03),尽管对OVA/Ad具有高度特异性,但对所测试的12种H-2单倍型中的6种的同种异体脾细胞有反应。对每种特定H-2单倍型的反应性需要某些品系小鼠B细胞上存在的非主要组织相容性复合体(MHC)基因产物的表达。所有的同种异体反应性应答都受MHC限制,并被II类特异性和L3T4特异性单克隆抗体抑制。非MHC基因产物X是一种新的淋巴细胞刺激决定簇,在有xid缺陷的小鼠中不表达。我们支持一种模型,该模型提出X和II类分子有两个独立的位点(或受体)。与先前的同种异体反应性模型相反,抗MHC位点不是针对外来II类分子上自身II类表位的多态性受体,而是针对自身和同种异体II类分子上都存在的保守决定簇。如果T细胞克隆Ly1-03上只有一种抗原受体,那么抗X受体必须结合在免疫原性OVA上发现的交叉反应决定簇以及细胞表面膜上表达的非MHC编码基因产物。我们进一步推测,II类加“X”识别可能是同种异体反应性以及自身反应性应答的一般规则。因此,同种异体II类和同种异体I类反应性T细胞相似之处在于,两者在激活之前都结合一种非MHC编码基因产物。